TG THERAPEUTICS, INC. — All Filings
1,000 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
10-Q/A
10KSB
10KSB/A
10QSB
10QSB/A
144
144/A
25
25/A
3
3/A
4
4/A
424B1
424B3
424B5
5
5/A
8-A12B
8-K
8-K/A
ARS
CERTAMX
CERTNAS
CORRESP
CT ORDER
D
D/A
DEF 14A
DEF 14C
DEFA14A
DEFC14A
DEFR14A
DEFS14A
EFFECT
NT 10-K
NT 10-Q
POS AM
POS462B
PRE 14A
PRE 14C
PREC14A
PRER14A
PRER14C
PRRN14A
PX14A6G
REGDEX
REGDEX/A
RW
S-1
S-1/A
S-3
S-3/A
S-3ASR
S-8
SB-2
SB-2/A
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G/A | — | 0000102909-26-002442 | Mar 27, 2026 | — |
| 8-K | FORM 8-K | 0001437749-26-009253 | Mar 20, 2026 | Mar 18, 2026 |
| 10-K | FORM 10-K | 0001437749-26-006133 | Feb 27, 2026 | Dec 31, 2025 |
| 8-K | FORM 8-K | 0001437749-26-005733 | Feb 26, 2026 | — |
| 4 | FORM 4 | 0001437749-26-002439 | Jan 29, 2026 | Jan 28, 2026 |
| 8-K | FORM 8-K | 0001437749-26-001194 | Jan 13, 2026 | — |
| 4 | FORM 4 | 0001437749-26-001016 | Jan 9, 2026 | Jan 8, 2026 |
| 4 | FORM 4 | 0001437749-26-001015 | Jan 9, 2026 | Jan 8, 2026 |
| 4 | FORM 4 | 0001437749-25-036358 | Nov 25, 2025 | Nov 24, 2025 |
| 144 | — | 0001959173-25-007234 | Nov 24, 2025 | — |
| 4 | FORM 4 | 0001437749-25-033888 | Nov 7, 2025 | Nov 5, 2025 |
| 10-Q | FORM 10-Q | 0001437749-25-033363 | Nov 5, 2025 | Sep 30, 2025 |
| 8-K | FORM 8-K | 0001437749-25-032658 | Nov 3, 2025 | — |
| 4 | FORM 4 | 0001437749-25-028952 | Sep 12, 2025 | Sep 11, 2025 |
| 144 | — | 0001959173-25-005946 | Sep 11, 2025 | — |
| S-8 | FORM S-8 | 0001437749-25-025753 | Aug 8, 2025 | — |
| S-3ASR | FORM S-3ASR | 0001437749-25-025771 | Aug 8, 2025 | — |
| 10-Q | FORM 10-Q | 0001437749-25-025745 | Aug 8, 2025 | Jun 30, 2025 |
| 8-K | FORM 8-K | 0001437749-25-024480 | Aug 4, 2025 | — |
| 4 | FORM 4 | 0001437749-25-020546 | Jun 16, 2025 | Jun 12, 2025 |
| 4 | FORM 4 | 0001437749-25-020545 | Jun 16, 2025 | Jun 12, 2025 |
| 4 | FORM 4 | 0001437749-25-020543 | Jun 16, 2025 | Jun 12, 2025 |
| 4 | FORM 4 | 0001437749-25-020541 | Jun 16, 2025 | Jun 12, 2025 |
| 4 | FORM 4 | 0001437749-25-020540 | Jun 16, 2025 | Jun 12, 2025 |
| 8-K | FORM 8-K | 0001437749-25-020335 | Jun 13, 2025 | Jun 12, 2025 |
| 144 | — | 0001959173-25-004055 | Jun 13, 2025 | — |
| 10-Q | FORM 10-Q | 0001437749-25-015804 | May 9, 2025 | Mar 31, 2025 |
| 8-K | FORM 8-K | 0001437749-25-014402 | May 5, 2025 | — |
| ARS | ARS | 0001437749-25-013863 | Apr 30, 2025 | Dec 31, 2024 |
| DEFA14A | FORM DEFA14A | 0001437749-25-013861 | Apr 30, 2025 | — |
| DEF 14A | FORM DEF 14A | 0001437749-25-013860 | Apr 30, 2025 | Jun 12, 2025 |
| SCHEDULE 13G/A | — | 0002052113-25-002013 | Apr 30, 2025 | — |
| PRE 14A | FORM PRE 14A | 0001437749-25-012371 | Apr 18, 2025 | Jun 12, 2025 |
| 4 | FORM 4 | 0001437749-25-008284 | Mar 18, 2025 | Mar 17, 2025 |
| 4 | FORM 4 | 0001437749-25-007052 | Mar 11, 2025 | Mar 10, 2025 |
| 10-K | FORM 10-K | 0001437749-25-005908 | Mar 3, 2025 | Dec 31, 2024 |
| 8-K | FORM 8-K | 0001437749-25-005802 | Mar 3, 2025 | — |
| 4 | FORM 4 | 0001437749-25-002292 | Jan 30, 2025 | Jan 29, 2025 |
| 4 | FORM 4 | 0001437749-25-002290 | Jan 30, 2025 | Jan 29, 2025 |
| 8-K | FORM 8-K | 0001437749-25-001106 | Jan 14, 2025 | — |
| SCHEDULE 13G/A | — | 0000932471-25-000038 | Jan 8, 2025 | — |
| 4 | FORM 4 | 0001437749-25-000662 | Jan 7, 2025 | Jan 3, 2025 |
| 144 | — | 0001959173-25-000144 | Jan 6, 2025 | — |
| 144 | — | 0001959173-25-000097 | Jan 3, 2025 | — |
| SC 13G/A | TG THERAPEUTICS, INC | 0000902664-24-006638 | Nov 14, 2024 | — |
| 4 | FORM 4 | 0001437749-24-034597 | Nov 12, 2024 | Nov 11, 2024 |
| 4 | FORM 4 | 0001437749-24-034595 | Nov 12, 2024 | Nov 11, 2024 |
| 144/A | — | 0001959173-24-007724 | Nov 12, 2024 | — |
| 144 | — | 0001959173-24-007713 | Nov 12, 2024 | — |
| 144 | — | 0001959173-24-007703 | Nov 12, 2024 | — |